JHS Svendgaard Laboratories share price
NSE: JHSBSE: 532771Personal ProductsSmall Cap
Last close ₹8.41down ₹0.44 (4.97%)BSE ₹8.49
Share price at the NSE close on 23 Oct 2026. Previous close ₹8.85.
52-week range of traded prices to 23 Oct 2026
₹6.26Low, 30 Mar 2026₹13.90High, 27 Oct 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹74 Cr3,087th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Jul 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- −1.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- −2.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Jul 2026
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day.
- 63,248
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 11 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹30 Crdown 7.08%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹1.09 CrQuarter to Mar 2026: −₹3.57 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 3.6%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 7 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2024, part of the business was demerged on 11 Sep 2023, and figures before the change include the part that left.
| ₹ crore | Sep 2024Filed 14 Nov | Dec 2024Filed 12 Feb | Mar 2025Filed 12 Jun | Jun 2025Filed 13 Aug | Sep 2025Filed 29 Apr | Dec 2025Filed 10 Feb | Mar 2026Filed 27 Jul | Jun 2026Filed 11 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.7 | 22.7 | 25.2 | 23.5 | 22.3 | 23.3 | 32.7 | 30.4 |
| Net profit | −10.3 | −1.8 | −7.0 | 1.1 | −0.2 | 0.8 | −3.6 | 1.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −52.4% | −8.1% | −27.6% | 4.5% | −0.9% | 3.4% | −10.9% | 3.6% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Oral Care Manufacturing, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2024: days before it are of the company before the change.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 7% of 1,127 trading days over the last 5 years.
LowestHighest
Its median0.8Industry median5.6
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | With the demerger reinvestedReturn with the demerger reinvested. The yearly price growth with the price before the demerger multiplied by the demerger's price factor (its opening price on the ex-date over the close before it), plus the average dividend yield: the return of a holder who put the value of the shares of the company that was split off back into this share on the ex-date. | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|---|
| 1 year | −41.4% | – | – | – | 0.0% |
| 3 years | −25.0% | −23.6% | – | – | 0.0% |
| 5 years | −20.0% | −19.1% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Return a year is the share as it traded across the demerger; the next column is the same return with the demerger reinvested, empty for a window with no demerger in it. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Personal Care, 21 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to JHS Svendgaard Laboratories in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
JHS Svendgaard Laboratories is not on the chart: it has no P/E today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Macobs TechnologiesMACOBSTECH | 188 | 64.8 | 4.5 | – | – | – | 8.3% | – | 0.00% |
 H. R. Hygiene ProductsHRHYGIENE | 138 | – | – | – | – | – | – | – | 0.00% |
 Thrive Future HabitatsTHRIVE | 96 | – | 1.8 | – | −29.8% | – | −5.3% | −6.8% | 0.00% |
 Aakaar Medical TechnologiesAAKAAR | 90 | 13.6 | 1.7 | – | – | – | 12.2% | – | 0.00% |
 RavelcareRAVEL | 63 | 12.3 | 1.7 | – | – | – | 13.8% | – | 0.00% |
 Medistep HealthcareMEDISTEP | 30 | 5.1 | 0.8 | 4.2 | – | – | 15.8% | – | 0.00% |
 Novateor Research LaboratoriesNOVATEOR | 23 | 211.6 | 2.0 | – | +37.8% | +32.9% | 1.0% | – | 0.00% |
 Paramount Cosmetics (India)PARMCOS-B | 17 | 78.5 | 0.8 | 25.5 | −5.9% | – | 1.1% | 1.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 26 Dec 2011 | Dividend | ₹0.75 |
| 22 Dec 2010 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.50 |
| 10 Sep 2009 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.25 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
17 Sep · General Updates
Aug 2026
JHS Svendgaard Laboratories share price by year
Each calendar year to 2025.JHS Svendgaard Laboratories share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 9.82 | −53.5% | 23.23 | 9.59 |
| 2024 | 21.12 | −17.0% | 38.15 | 15.55 |
| 2023Demerger | 25.45 | +13.9% | 29.25 | 14.20 |
| 2022 | 22.35 | −18.7% | 31.70 | 20.10 |
| 2021 | 27.50 | +14.3% | 32.80 | 18.90 |
| 2020 | 24.05 | +58.7% | 26.60 | 6.90 |
| 2019 | 15.15 | −55.9% | 34.70 | 13.05 |
| 2018 | 34.35 | −54.2% | 74.70 | 24.05 |
| 2017 | 75.05 | +102.3% | 80.70 | 36.95 |
| 2016 | 37.10 | +44.9% | 45.15 | 19.05 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. With the demerger of 11 Sep 2023 reinvested, the change in 2023 is +20.3%.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 8.78 | 8.78 | 8.41 | 8.41 | 8.43 | 63,248 |
| 22 Oct 2026 | 9.31 | 9.65 | 8.85 | 8.85 | 8.89 | 82,174 |
| 21 Oct 2026 | 9.84 | 9.94 | 9.00 | 9.31 | 9.35 | 81,833 |
| 19 Oct 2026 | 9.44 | 9.47 | 9.10 | 9.47 | 9.41 | 93,712 |
| 16 Oct 2026 | 8.82 | 9.10 | 8.63 | 9.02 | 8.98 | 1,47,252 |
| 15 Oct 2026 | 8.99 | 9.35 | 8.55 | 8.90 | 8.74 | 76,192 |
| 14 Oct 2026 | 8.74 | 9.18 | 8.67 | 8.99 | 9.03 | 1,32,361 |
| 13 Oct 2026 | 9.01 | 9.25 | 8.64 | 8.75 | 8.88 | 1,75,356 |
| 12 Oct 2026 | 9.35 | 9.69 | 9.08 | 9.08 | 9.12 | 3,43,312 |
| 9 Oct 2026 | 9.30 | 9.98 | 9.15 | 9.55 | 9.42 | 1,72,341 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Demerger history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 11 Sep 2023 | Demerger | 0.9465 | Part of the business became a separate company. The factor is the opening price on the ex-date divided by the previous close. The chart shows earlier prices with the demerger reinvested. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- Legal name
- JHS Svendgaard Laboratories Limited
- NSE symbol
- JHS
- BSE code
- 532771
- ISIN
- INE544H01014
- Industry
- Personal Products
- Listed
- Oct 2006
- Face value
- ₹10
- CIN
- L74110HP2004PLC027558
- Corporate identity number, the registrar of companies' code for it